Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.
| Data(s) |
2010
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_8793178A5C37 isbn:1778-7254[electronic], 1297-319X[linking] pmid:20471890 doi:10.1016/j.jbspin.2010.02.021 isiid:000281783700006 |
| Idioma(s) |
en |
| Fonte |
Joint, Bone, Spine : Revue du Rhumatisme, vol. 77, no. 4, pp. 313-318 |
| Palavras-Chave | #Aged; Aged, 80 and over; Antibodies, Anti-Idiotypic/blood; Antibodies, Monoclonal/blood; Antibodies, Monoclonal/therapeutic use; Arthritis, Rheumatoid/drug therapy; Biological Markers/blood; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Logistic Models; Male; Middle Aged; Time Factors; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/article article |
